Luis Rios, PhD is the Founder and CEO of Fission Pharma, a start-up focused on revolutionizing the treatment of inflammatory diseases. With a background in chemical and systems biology, Luis serves as a Longevity Biotech Fellow at Longevity Biotech Fellowship, Director of Drug Discovery at ImmuneAGE Pharma, Consultant at Longitude Capital, and Scientific Advisor at Healthspan Capital. Previously, Luis was a Senior Scientific Partner at Vine Ventures, a Co-Founder at Avia Pervia, and a Doctoral Student at Stanford University. Luis also holds a Bachelor of Arts in Molecular and Cell Biology from the University of California, Berkeley.
January, 2023 - present
Vice President, North American Logistics / Global Parcel at PVH
Vp, Regional Supply Chain at Amgen
Executive Director Supply Chain at Amgen
Executive Director, US Supply Chain Lead at Amgen
Managing Director - Macro Trading Risk Management at Morgan Stanley
Access the worlds's biggest network of public org charts
Learn more